Global Hydrocephalus Market - Industry Trends and Forecast to 2031
The Global hydrocephalus market is expected to reach USD 2,592,720.77 thousand by 2031 from USD 1,587,759.20 thousand in 2023, growing with a CAGR of 6.5% in the forecast period of 2024 to 2031.
Market SegmentationGlobal Hydrocephalus Market, By Type (Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, and Ex-Vacuo Hydrocephalus), Diagnostic & Treatment (Diagnosis and Treatment), End Users (Hospitals, Clinics, Diagnostic Centers, and Academic Institutions and Research Organizations), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Ireland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031
Overview of Global Hydrocephalus Market Dynamics
Driver
• Increasing incidence of neurological conditions
Restraint
• Poor reimbursement policies
Opportunity
• Growing support by healthcare organizations and government bodies
Market PlayersSome of the key market players operating in the global hydrocephalus market are: • Aesculap, Inc. – a B. Braun company
• Integra LifeSciences
• G.SURGIWEAR LTD
• MÖLLER Medical GmbH
• Anuncia Inc.
• CHRISTOPH MIETHKE GMBH & CO. KG
• KARL STORZ SE & Co. KG
• Próteses, inc.
• Medtronic
• natus
• Desu Medical
• Bicakcilar
• Spiegelberg GmbH & Co.KG
• Sophysa
• KANEKA MEDIX CORP
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.